Bioage Labs revenue was $10.32M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $2.8M, down 9.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BIOA annual revenue was $9.0M, with Infinity% growth year-over-year.
BIOA past revenue growth
How has BIOA's revenue growth performed historically?
On Invalid Date, Bioage Labs (NASDAQ: BIOA) reported Q1 2026 revenue of $2.77 million up 91.04% year over year. In the same quarter last year, Bioage Labs's revenue was $1.45 million.
What was Bioage Labs's revenue in 2025?
Bioage Labs's annual revenue for the twelve months ending Dec 31, 2025 was $9.00 million, a Infinity% increase year over year.
How much does Bioage Labs make in a day?
Based on Bioage Labs annual revenue for the past three years, BIOA makes an average of $8,214.61 per day.
What was Bioage Labs's annual revenue growth in the past year?
As of Q2 2026, Bioage Labs's revenue has grown 610.96% year over year. This is 603.52 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 7.44%. Bioage Labs's revenue in the past year totaled $10.32 million.
How much does Bioage Labs make in a year?
Bioage Labs's revenue by year for the past three years is:
Bioage Labs's revenue for the twelve months ending Dec 31, 2025 was $9.00 million, a Infinity% increase year over year.
Bioage Labs's annual revenue for Dec 31, 2024 was $0.00, a N/A decrease from 2023.
Bioage Labs's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.